Nvest Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$758K Sell
9,688
-1,389
-13% -$112K 0.24% 81
2026
Q1
$960K Buy
11,077
+6
+0.1% +$575 0.36% 64
2025
Q4
$1.06M Buy
11,071
+2,079
+23% +$202K 0.44% 52
2025
Q3
$856K Sell
8,992
-2,280
-20% -$210K 0.49% 48
2025
Q2
$983K Buy
11,272
+696
+7% +$59K 0.51% 48
2025
Q1
$950K Sell
10,576
-12
-0.1% -$1.07K 0.51% 49
2024
Q4
$846K Buy
10,588
+536
+5% +$46.4K 0.43% 59
2024
Q3
$905K Buy
10,052
+633
+7% +$53.3K 0.52% 51
2024
Q2
$741K Buy
9,419
+1,655
+21% +$136K 0.46% 51
2024
Q1
$677K Buy
7,764
+1,171
+18% +$99.9K 0.45% 51
2023
Q4
$543K Buy
6,593
+1,801
+38% +$137K 0.43% 45
2023
Q3
$375K Buy
4,792
+1,048
+28% +$87.7K 0.35% 47
2023
Q2
$330K Buy
+3,744
New +$322K 0.29% 52
2022
Q2
Sell
-5,497
Closed -$610K 62
2022
Q1
$610K Buy
+5,497
New +$581K 0.5% 46

Other funds holding MDT

Nvest Financial's MDT Position: Q2 2026 in Review

Nvest Financial reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $112K and leaving 9,688 shares worth $758K. The position accounts for 0.24% of the portfolio, ranked #81.

Nvest Financial first reported a position in MDT in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.06M in Q4 2025. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nvest Financial held 9,688 shares of Medtronic worth $758K as of Q2 2026.
  • Nvest Financial sold 1,389 Medtronic shares in Q2 2026, an estimated $112K.
  • Medtronic made up 0.24% of Nvest Financial's portfolio in Q2 2026, its #81 holding.
  • Nvest Financial first reported a position in Medtronic in Q1 2022 and has held it in 14 quarters since.
  • Nvest Financial's Medtronic position peaked at $1.06M in Q4 2025.
  • 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nvest Financial's 13F filing for Q2 2026, filed 30 Jul 2026.